CURN — Kinarus Therapeutics Holding AG Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣26.04m
- CH₣26.17m
Annual cashflow statement for Kinarus Therapeutics Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.94 | -0.007 | -0.143 | -34.7 | -49.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.092 | -0.392 | -0.271 | 29.6 | 45.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.161 | 0.015 | 0.055 | -0.999 | 1.14 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.662 | -0.378 | -0.359 | -4.65 | -1.89 |
| Capital Expenditures | 0 | — | — | -0.004 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.899 | 0 | 5.48 | -0.006 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Cash from Investing Activities | 0 | -0.899 | 0 | 5.48 | -0.006 |
| Financing Cash Flow Items | -0.003 | -0.001 | 0 | -0.087 | -0.042 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.607 | 0.523 | 0.42 | 0.392 | 0.558 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.063 | -0.817 | 0.061 | 1.22 | -1.33 |